Skip to content
The Nexus
BUSINESSAug 4 · 11:13 UTCCNBC TOP

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Pfizer exceeded quarterly revenue estimates due to strong performance from non-Covid products and raised the lower end of its revenue guidance. However, the company reduced its full-year revenue forecast for Covid products to $4 billion from $5 billion.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Pfizerorganizationnon-Covid productstopicCovid productstopicrevenue guidancetopicquarterly estimatestopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting